abstract |
The present invention provides: a novel compound represented by chemical formula 1, or a salt thereof; and a pharmaceutical composition for treating lung cancer, containing same. A pyrimidine derivative compound represented by chemical formula 1 effectively inhibits the growth of cancer cells with an ALK mutation and an EGFR mutation, thereby being effectively usable in the treatment of lung cancer. |